Edward Dean Wolf, a pioneer in nanofabrication who joined Cornell in 1978 as the first director of what would become the Cornell Nanoscale Science and Technology Facility, died March 11 in Ithaca. He was 87.
Expert panelists Thomas Garrett and Damon Wilson will examine the threats democracies around the world are confronting, and what governments and citizens can do to fight back, on April 24.
PARADIM has received a second award of $22.5 million from the National Science Foundation to fund another five years of enabling scientists, engineers and entrepreneurs nationwide to design and create new inorganic materials for use in electronics.
Astronomer Ray Jayawardhana, the Harold Tanner Dean of Arts and Sciences, is featured in the new PBS NOVA/BBC documentary on neutrinos, “Particles Unknown,” airing Oct. 6.
The FDA announced the nasal spray based form of Narcan – which reverses opioid overdoses and previously required a prescription – can now be sold over the counter.
Gov. Andrew Cuomo has accepted new proposals to expand access to telehealth – developed with the Reimagine New York Commission Telehealth Working Group, co-chaired by President Martha E. Pollack.
Christine D. Lovely, associate vice chancellor and chief human resources officer at the University of California, Davis, will succeed Mary Opperman as Cornell's next vice president and chief human resources officer, effective Aug. 30.
Nicola Dell’s work in human-computer interaction improves computer security and privacy for victims of intimate partner violence, strengthens digital privacy in non-Western contexts, and informs technology that supports home health care workers.
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.
